Sage Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Sage Therapeutics, Inc. has filed 818 SEC EDGAR filings since 21 Jan 2014

SEC filing history

Showing 51-75 of 818 matching filings.

Per page
25
Current page
3
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36544

ARS

Filing date
24 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36544

DEFA14A

Filing date
24 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36544

DEF 14A

Filing date
24 Apr 2025
Reporting date
23 Apr 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-88275

SCHEDULE 13G/A filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
02 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-88275

SCHEDULE 13G filing

Filing date
01 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88275

SCHEDULE 13G/A filing

Filing date
07 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88275

SCHEDULE 13G/A filing

Filing date
06 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .